PALISADE BIO, INC. financial data

Symbol
PALI on Nasdaq
Location
Carlsbad, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 10 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 235% % -47%
Debt-to-equity 75% % 160%
Return On Equity -241% % -62%
Return On Assets -137% % -19%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 149,003,210 shares 11107%
Common Stock, Shares, Outstanding 9,119,152 shares 661%
Entity Public Float $4,300,000 USD -63%
Common Stock, Value, Issued $91,000 USD 727%
Weighted Average Number of Shares Outstanding, Basic 7,473,898 shares 398%
Weighted Average Number of Shares Outstanding, Diluted 7,473,898 shares 398%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $0 USD -100%
Research and Development Expense $16,000,000 USD
General and Administrative Expense $5,354,000 USD -12%
Operating Income (Loss) $11,457,000 USD 22%
Nonoperating Income (Expense) $231,000 USD -59%
Net Income (Loss) Attributable to Parent $11,226,000 USD 20%
Earnings Per Share, Basic -1 USD/shares 90%
Earnings Per Share, Diluted -1 USD/shares 90%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $5,227,000 USD -35%
Assets, Current $6,828,000 USD -23%
Property, Plant and Equipment, Net $0 USD -100%
Operating Lease, Right-of-Use Asset $0 USD -100%
Other Assets, Noncurrent $119,000 USD -63%
Assets $6,973,000 USD -25%
Accounts Payable, Current $1,426,000 USD 290%
Employee-related Liabilities, Current $621,000 USD 38%
Accrued Liabilities, Current $1,220,000 USD -19%
Liabilities, Current $3,478,000 USD 30%
Operating Lease, Liability, Noncurrent $0 USD -100%
Other Liabilities, Noncurrent $283,000 USD
Liabilities $3,761,000 USD 38%
Retained Earnings (Accumulated Deficit) $141,000,000 USD
Stockholders' Equity Attributable to Parent $3,212,000 USD -51%
Liabilities and Equity $6,973,000 USD -25%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $2,333,000 USD 27%
Net Cash Provided by (Used in) Financing Activities $258,000 USD -113%
Common Stock, Shares Authorized 280,000,000 shares 0%
Common Stock, Shares, Issued 9,119,152 shares 661%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $2,591,000 USD -124%
Interest Paid, Excluding Capitalized Interest, Operating Activities $1,000 USD -50%
Deferred Tax Assets, Valuation Allowance $32,468,000 USD 12%
Deferred Tax Assets, Gross $32,599,000 USD 12%
Operating Lease, Liability $122,000 USD -49%
Depreciation $1,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid $128,000 USD -51%
Operating Lease, Liability, Current $0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year One $94,000 USD -31%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6,000 USD -75%
Deferred Tax Assets, Operating Loss Carryforwards $27,383,000 USD 11%
Additional Paid in Capital $146,945,000 USD 5.6%
Share-based Payment Arrangement, Expense $85,000 USD -7.6%
Interest Expense $11,000 USD -15%